RESMED INC — Director's Dealing 2016

Feb 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-02-25

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-25	ResMed Common Stock	S	17191	$57.59	Disposed	132136.132	Direct
2016-02-26	ResMed Common Stock	S	5900	$57.59	Disposed	126236.132	Direct
2016-02-26	ResMed Common Stock	S	6909	$57.67	Disposed	119327.132	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $57.50 to $58.00. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.